课题基金 / 基金详情

Correlates of Vaccine-Induced, Tunable-Protection in an Outbred Tularemia Model

Correlates of Vaccine-Induced, Tunable-Protection in an Outbred Tularemia Model
远交兔热病模型中疫苗诱导的可调节保护的相关性
批准号:
9217589
负责人:
Eileen M. Barry
金额:
$73.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-02-15 至 2021-01-31

项目摘要

项目成果

Eileen M. Barry的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Francisella tularensis is the causitive agent of tularemia, a severe zoonotic disease in humans with fatality rates exceeding 30% in untreated subjects. Infection following inhalation causes the most severe form of disease and combind with its high virulence and history of weaponization makes this pathogen a concern for use as a biological weapon. Development of a vaccine that protects against aerosol infection is a priority. We have engineered a series of live attenuated vaccine candidates based on the highly virulent Schu S4 strain that exhibit a range of protective capacities in the mouse and rabbit models of respiratory challenge. Our studies have confirmed that rabbits are an excellent model of human pneumonic tularemia and a highly relevant model for evaluating tularemia vaccines as they display similar resistance to attenuated strains and susceptibility to virulent strains as humans. We hypothesize that the outbred human-relevant, rabbit model will allow us to identify correlates of protection using the collection of vaccine strains that confer a range (0% to 83%) of protective efficacies against lethal aerosol challenge. This grant seeks to understand the mechanism(s) underlying this protection. Our hypothesis is that effective vaccination in the rabbit model is a product of i) induction of particular, Ag-specific responses and/or ii) the immunogen's persistence and immuno-stimulatory properties. The first aim will identify the bacterial Ag(s) recognized specifically by protective immune responses. The second aim will explore the humoral and cellular immune response as well as the role of persistence and immune stimulation by F. tularensis derivatives in protection against challenge. The third aim will evaluate the efficacy of a subunit vaccine and an optimized live attenuated vaccine against inhalation of F. tularensis. The information gained under this proposal will expand our understanding of the humoral and cellular immune response to tularemia vaccines, the importance of these responses in protection against tularemia in the rabbit and the relevance to protection in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advanced Development of a Combined Shigella-ETEC Vaccine
  • 批准号:
    10704845
  • 项目类别:
  • 资助金额:
    $105.35万
  • 财政年份:
    2023
  • 负责人:
    Eileen M. Barry
  • 依托单位:
Initial clinical evaluation of attenuated Shigella flexneri 2a live vector expressing enterotoxigenic Escherichia coli antigens, strain CVD 1208S-122.
  • 批准号:
    10407441
  • 项目类别:
  • 资助金额:
    $71.54万
  • 财政年份:
    2020
  • 负责人:
    Eileen M. Barry
  • 依托单位:
Initial clinical evaluation of attenuated Shigella flexneri 2a live vector expressing enterotoxigenic Escherichia coli antigens, strain CVD 1208S-122.
  • 批准号:
    10212188
  • 项目类别:
  • 资助金额:
    $152.92万
  • 财政年份:
    2020
  • 负责人:
    Eileen M. Barry
  • 依托单位:
An Expanded Multivalent Vaccine to Prevent MDR Shigella and ETEC Disease
  • 批准号:
    10584477
  • 项目类别:
  • 资助金额:
    $97.34万
  • 财政年份:
    2019
  • 负责人:
    Eileen M. Barry
  • 依托单位:
海外基金